Liver Cancer  >>  oxaliplatin  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00869271: Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer

Completed
4
200
RoW
tac + folfox4, Folfox4
Fudan University
Unresectable Liver Metastasis of Colorectal Cancer
12/07
12/07
NCT00510627: Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases

Withdrawn
4
0
US
Radiofrequency Ablation (RFA), RF3000 Radiofrequency (RF) Generators, LeVeen Electrode, Co-Access Electrode, Soloist Electrode, SuperSlim Electrode, Chemotherapy, Oxaliplatin containing chemotherapy regimen, Irinotecan containing chemotherapy regimen, An anti-EGFR monoclonal antibody-containing regimen, Other
Boston Scientific Corporation
Metastatic Liver Cancer, Secondary Liver Cancer, Liver Neoplasm
 
12/10
AVAMET, NCT01493713 / 2011-000143-24: Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer

Completed
4
83
Europe
Evaluate the correlation of overall different objective response.
Grupo Espanol Multidisciplinario del Cancer Digestivo
Colorectal Cancer, Hepatic Metastasis
12/14
12/17

Download Options